well said marcol.
I emailed the company a few months ago and they informed me the trials were still progressing and they will inform the market when its finished.
If the trial is progressing overschedule could be a good sign to a wider rollout perhaps?
Then again, could be having a hiccup. To date, i haven't read about any trials that did not lead to a wider rollout.
First class software here i reckon.